Concepedia

Cindy S.W. Tong

CS

Statistics

Publications

16

Citations

1.1K

H-Index

13

Active since

2001

Affiliations

Chinese University of Hong Kong(Current)

Janssen (United States)

University of Hong Kong

UNSW Sydney

VA San Diego Healthcare System

Cindy S.W. Tong is an author at Chinese University of Hong Kong specializing in medicine, diabetes mellitus, and sodium-glucose cotransport.

Publications per year

2001–2024

16

Publications

16

Efficacy and Safety of Canagliflozin, a Sodium–Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes

Robert R. Henry, Payal Thakkar, Cindy S.W. Tong et al. · Diabetes Care · 2015 · 288 citations

, , +17

Over‐expression of FoxM1 stimulates cyclin B1 expression

Tommy W.C. Leung, Selma S.W. Lin, Anthony C. C. Tsang et al. · FEBS Letters · 2001 · 183 citations · Full text

, , +17

Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study

Kaj Stenlöf, William T. Cefalu, Kyoung‐Ah Kim et al. · Current Medical Research and Opinion · 2013 · 157 citations · Full text

, , +17

Diabetic Ketoacidosis With Canagliflozin, a Sodium–Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes

Anne L. Peters, Robert R. Henry, Payal Thakkar et al. · Diabetes Care · 2016 · 104 citations

, , +17

Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk

Larry Baum, Ho‐Keung Ng, Kam S. Woo et al. · Clinical Biochemistry · 2006 · 50 citations

, , +13

1–5 of 16